Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis

Fischer S, Rath T, Geppert CI, Manger B, Schett G, Neurath M, Atreya R (2017)

Publication Type: Journal article

Publication year: 2017

Journal

American Journal of Gastroenterology Springer Nature

Book Volume: 112

Pages Range: 1621-1623

Journal Issue: 10

DOI: 10.1038/ajg.2017.242

Authors with CRIS profile

Sören Fischer Department of Transfusion Medicine and Haemostaseology Carol-Immanuel Geppert Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Bernhard Manger Professur für Rheumatologie und Klinische Immunologie Georg Schett Lehrstuhl für Innere Medizin III Markus Neurath Lehrstuhl für Innere Medizin I Raja Atreya Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen (Heisenberg-Professur)

How to cite

APA:

Fischer, S., Rath, T., Geppert, C.-I., Manger, B., Schett, G., Neurath, M., & Atreya, R. (2017). Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis. American Journal of Gastroenterology, 112(10), 1621-1623. https://dx.doi.org/10.1038/ajg.2017.242

MLA:

Fischer, Sören, et al. "Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis." American Journal of Gastroenterology 112.10 (2017): 1621-1623.

BibTeX: Download